• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.06% Nasdaq Down 0.57%

    Synta Pharmaceuticals Corp. (SNTA)

    -NasdaqGM
    2.49 Down 0.21(7.62%) 2:37PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.69
    Open:2.73
    Bid:2.48 x 20100
    Ask:2.49 x 3600
    1y Target Est:9.58
    Beta:1.95
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:2.44 - 2.77
    52wk Range:1.85 - 4.97
    Volume:2,176,842
    Avg Vol (3m):1,452,670
    Market Cap:325.84M
    P/E (ttm):N/A
    EPS (ttm):-0.88
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SNTA

    Comparison

    Symbol% ChgMkt Cap
    SNTADown 7.62%325.84M
    INFIDown 5.30%673.63M
    NVSUp 0.03%250.20B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.77
    Quarterly EPS Est (Mar-15) :-0.20
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback